Capula Management »

Sarepta Therapeutics shares owned by Capula Management

Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by Capula Management from 13F filings

Historical chart of Capula Management investment in Sarepta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics held by Capula Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics by Capula Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $221k 2.3k 96.43
2023-09-30 $1.4M 12k 121.22

More positions owned by Capula Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vaneck Etf Trust Semiconductr Etf (SMH)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Meta Platforms Cl A (META)
Amazon Put Option (AMZN)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Alphabet Cap Stk Cl C (GOOG)
Pioneer Natural Resources (PXD)
Select Sector Spdr Tr Rl Est Sel Sec (XLRE)
Spdr Ser Tr S&p Regl Bkg Call Option (KRE)
Ishares Tr Msci Emg Mkt Etf (EEM)
Select Sector Spdr Tr Financial (XLF)
Capri Holdings SHS (CPRI)

View all positions for Capula Management

Top funds holding Sarepta Therapeutics

Vanguard Group
Henderson Group
venBio Select Advisor
Wellington Management Company
Citadel Advisors
Bank of New York Mellon
Deutsche Bank Aktiengesellschaft
Jpmorgan Chase & Co
Bank of America Corporation
Caption Management
Casdin Capital
Norges Bank Investment Management
EcoR1 Capital
Royal Bank of Canada
Millennium Management

View all funds holding Sarepta Therapeutics